Analysts expect MAIA Biotechnology, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 99.02 M | 100.26 M | ||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 81.97 M | 87.49 M | ||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 90.49 M | 93.87 M |
Analysts expect MAIA Biotechnology, Inc. to report earnings per share of -0.13 for Q3 26, against a range of -0.14 to -0.12. The most recent reported quarter, Q2 26, came in at -0.13, a 7.1% beat against the -0.14 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.35 | -0.32 | -0.16 | -0.18 | -0.27 | -0.10 | -0.16 | -0.13 | - | - | - | - | - | - | - | - | ||
| High Estimate | -0.48 | -0.32 | -0.16 | -0.21 | -0.18 | -0.12 | -0.15 | -0.13 | -0.12 | -0.12 | -0.15 | -0.14 | 0.03 | 0.12 | -0.02 | -0.08 | ||
| Low Estimate | -0.52 | -0.36 | -0.18 | -0.25 | -0.20 | -0.14 | -0.19 | -0.15 | -0.14 | -0.14 | -0.17 | -0.18 | 0.03 | 0.12 | -0.02 | -0.10 | ||
| Consensus Estimate | -0.50 | -0.34 | -0.17 | -0.23 | -0.19 | -0.13 | -0.17 | -0.14 | -0.13 | -0.13 | -0.16 | -0.16 | 0.03 | 0.12 | -0.02 | -0.09 |